DHTKD1 and neoplasm: In addition, the in vivo anti-tumor experiment showed that Ad-hTERT-E1a-HN could significantly suppress tumor growth, especially via intratumoral injection, which elicited a complete response to treatment and conferred the longest mean survival time of 63 days observed in this study.